Beatrix Bartók
- Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies 19
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 11
- Autoimmune and Inflammatory Disorders Research 5
- Immunology top 5%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 28
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Cancer Research top 5%
-
- Lymphoma Diagnosis and Treatment 9
-
- PI3K/AKT/mTOR signaling in cancer 5
- Protein Tyrosine Phosphatases 4
- Co-authors
- Gary S. FiresteinF. MatzkiesYing GuoJohn S. SundyChantal TassetNeelufar MozaffarianMark C. GenoveseDavid L. Boyle
- Cited by
- RheumatologyHematologyImmunology
- Journals
- Annals of the Rheumatic Diseases (12 papers)Modern Rheumatology (3 papers)Lara D. Veeken (3 papers)
- Partner nations
- United StatesJapanBelgium
In The Last Decade
Beatrix Bartók
40 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Rheumatology 1.3k
- Hematology 516
- Immunology 734
- Genetics 348
- Cancer Research 375
Countries citing papers authored by Beatrix Bartók
This map shows the geographic impact of Beatrix Bartók's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatrix Bartók with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatrix Bartók more than expected).
Fields of papers citing papers by Beatrix Bartók
This network shows the impact of papers produced by Beatrix Bartók. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatrix Bartók. The network helps show where Beatrix Bartók may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Beatrix Bartók, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 95 | |
| 4 | Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trialbreakdown → | 2021 | 163 |
| 5 | 2021 | 62 | |
| 6 | 2020 | 1 | |
| 7 | 2020 | 1 | |
| 8 | Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: FINCH1 Primary Outcome Results | 2019 | 16 |
| 9 | 2019 | 1 | |
| 10 | Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapybreakdown → | 2019 | 224 |
| 11 | 2015 | 45 | |
| 12 | 2014 | 33 | |
| 13 | 2013 | 43 | |
| 14 | 2013 | 30 | |
| 15 | 2012 | 87 | |
| 16 | 2011 | 7 | |
| 17 | Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritisbreakdown → | 2009 | 1527 |
| 18 | 2005 | 89 | |
| 19 | 2004 | 46 | |
| 20 | 2003 | 37 |
About Beatrix Bartók
Beatrix Bartók is a scholar working on Genetics, Hematology, Rheumatology, Pathology and Forensic Medicine and Immunology, having authored 40 papers that have together received 2.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (28 papers), Rheumatoid Arthritis Research and Therapies (19 papers), Chronic Myeloid Leukemia Treatments (11 papers), Lymphoma Diagnosis and Treatment (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Autoimmune and Inflammatory Disorders Research (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Protein Tyrosine Phosphatases (4 papers). The work is most often cited by research in Rheumatology (1.3k citations), Hematology (516 citations), Immunology (734 citations), Genetics (348 citations) and Cancer Research (375 citations). Beatrix Bartók has collaborated with scholars based in United States, Japan and Belgium. Frequent co-authors include Gary S. Firestein, F. Matzkies, Ying Guo, John S. Sundy, Chantal Tasset, Neelufar Mozaffarian, Mark C. Genovese, David L. Boyle, Tsutomu Takeuchi and Jacques‐Eric Gottenberg. Their work appears in journals such as Annals of the Rheumatic Diseases, Modern Rheumatology, Lara D. Veeken, Journal of Crohn s and Colitis and Rheumatology and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.